(-0.20%) 5 056.75 points
(-0.04%) 37 977 points
(-0.50%) 17 484 points
(-1.05%) $81.07
(-2.76%) $1.936
(-0.23%) $2 297.60
(0.19%) $26.71
(-0.54%) $943.10
(0.16%) $0.939
(0.33%) $11.13
(0.18%) $0.802
(0.11%) $93.56
0.00% $ 0.823
Live Chart Being Loaded With Signals
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers...
Stats | |
---|---|
Volumen de hoy | 44 894.00 |
Volumen promedio | 152 414 |
Capitalización de mercado | 9.63M |
EPS | $0 ( 2024-03-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.181 |
ATR14 | $0.0680 (56.62%) |
Volumen Correlación
IMV Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
NAKD | 0.952 |
MDXH | 0.943 |
GSMG | 0.941 |
SIRI | 0.94 |
AHPI | 0.939 |
TENX | 0.938 |
TSHA | 0.937 |
CSSE | 0.936 |
BCBP | 0.933 |
SINT | 0.933 |
10 Correlaciones Más Negativas | |
---|---|
KIN | -0.957 |
ATCX | -0.957 |
ALGM | -0.955 |
SRRA | -0.948 |
NCAC | -0.945 |
OBT | -0.942 |
INTA | -0.939 |
GXII | -0.939 |
ITI | -0.938 |
DHCAU | -0.937 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
IMV Inc Correlación - Moneda/Commodity
IMV Inc Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-4.61 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-4.61 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.0737 |
FY | 2020 |
Ingresos: | $3 000.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.0578 |
Financial Reports:
No articles found.
IMV Inc
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico